Detalles de la búsqueda
1.
Lowering the Acquisition of Multi-drug Resistant Organism (MDROs) with Pulsed-xenon (LAMP) Study: a cluster randomized controlled, double-blinded, interventional crossover trial.
Clin Infect Dis
; 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38743564
2.
A purified reconstituted bilayer matrix shows improved outcomes in treatment of non-healing diabetic foot ulcers when compared to the standard of care: Final results and analysis of a prospective, randomized, controlled, multi-centre clinical trial.
Int Wound J
; 21(4): e14882, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38606794
3.
The impact of the SARS-CoV-2 pandemic on the management of chronic limb-threatening ischemia and wound care.
Wound Repair Regen
; 30(1): 7-23, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34713947
4.
A Novel Macrophage-Activating Gel Improves Healing and Skin Quality After CO2 Laser Resurfacing of the Chest.
Dermatol Surg
; 48(12): 1312-1316, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36449873
5.
A multi-centre, single-blinded randomised controlled clinical trial evaluating the effect of resorbable glass fibre matrix in the treatment of diabetic foot ulcers.
Int Wound J
; 19(4): 791-801, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34418302
6.
A prospective clinical trial evaluating changes in the wound microenvironment in patients with chronic venous leg ulcers treated with a hypothermically stored amniotic membrane.
Int Wound J
; 19(1): 144-155, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33955178
7.
Wound repair, safety, and functional outcomes in reconstructive lower extremity foot and ankle surgery using a dehydrated amnion/chorion allograft membrane.
Int Wound J
; 19(8): 2062-2070, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35373506
8.
Multi-centre prospective randomised controlled clinical trial to evaluate a bioactive split thickness skin allograft vs standard of care in the treatment of diabetic foot ulcers.
Int Wound J
; 19(4): 932-944, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35080127
9.
Improved healing of chronic diabetic foot wounds in a prospective randomised controlled multi-centre clinical trial with a microvascular tissue allograft.
Int Wound J
; 19(4): 811-825, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34469077
10.
Use of a purified reconstituted bilayer matrix in the management of chronic diabetic foot ulcers improves patient outcomes vs standard of care: Results of a prospective randomised controlled multi-centre clinical trial.
Int Wound J
; 19(5): 1197-1209, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35001559
11.
Assessing the uncertainty of treatment outcomes in a previous systematic review of venous leg ulcer randomized controlled trials: Additional secondary analysis.
Wound Repair Regen
; 29(2): 327-334, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33556200
12.
Evidence supporting wound care end points relevant to clinical practice and patients' lives. Part 3: The Patient Survey.
Wound Repair Regen
; 29(1): 60-69, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33118249
13.
Bacterial protease activity as a biomarker to assess the risk of non-healing in chronic wounds: Results from a multicentre randomised controlled clinical trial.
Wound Repair Regen
; 29(5): 752-758, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34057796
14.
Matched-cohort study comparing bioactive human split-thickness skin allograft plus standard of care to standard of care alone in the treatment of diabetic ulcers: A retrospective analysis across 470 institutions.
Wound Repair Regen
; 28(1): 81-89, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31587418
15.
An observational pilot study using a purified reconstituted bilayer matrix to treat non-healing diabetic foot ulcers.
Int Wound J
; 17(4): 966-973, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32266774
16.
Evidence supporting wound care end points relevant to clinical practice and patients' lives. Part 2. Literature survey.
Wound Repair Regen
; 27(1): 80-89, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30315716
17.
Cost-utility of a biofilm-disrupting gel versus standard of care in chronic wounds: a Markov microsimulation model based on a randomised controlled trial.
J Wound Care
; 28(Sup7): S24-S38, 2019 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31295074
18.
Multicenter, randomized controlled, observer-blinded study of a nitric oxide generating treatment in foot ulcers of patients with diabetes-ProNOx1 study.
Wound Repair Regen
; 26(2): 228-237, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29617058
19.
An Economic Evaluation of the Impact, Cost, and Medicare Policy Implications of Chronic Nonhealing Wounds.
Value Health
; 21(1): 27-32, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29304937
20.
An aseptically processed, acellular, reticular, allogenic human dermis improves healing in diabetic foot ulcers: A prospective, randomised, controlled, multicentre follow-up trial.
Int Wound J
; 15(5): 731-739, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29682897